Advertisement

Maßnahmen zur Optimierung von Medikamentenverordnungen für ältere Menschen in Pflegeeinrichtungen

  • Sebastian Voigt-RadloffEmail author
  • Claudia Bollig
  • Gabriel Torbahn
  • Michael Denkinger
  • Jürgen Bauer
Cochrane Corner Geriatrie
  • 41 Downloads

Originalpublikation

Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P (2016) Interventions to optimise prescribing for older people in care homes. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD009095. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009095.pub3

Infobox

In dieser Serie wird Cochrane-Evidenz übersetzt und für die optimale Versorgung geriatrischer Patienten in Deutschland kommentiert. Dazu kooperiert Cochrane Deutschland mit der Deutschen Gesellschaft für Geriatrie e. V. und der Forschungsgruppe Medikation und Lebenssituation im Alter der Universitäten Heidelberg, Ulm und Freiburg.

Cochrane-Abstract

Hintergrund

Ein substanzieller Korpus an Evidenz zeigt, dass die Medikamentenverordnung für Bewohner von Pflegeeinrichtungen suboptimal ist und der Verbesserung bedarf. Daher ist es erforderlich, wirksame Interventionen zu identifizieren, um in diesem Kontext die Medikamentenverordnungen und Behandlungsergebnisse der Bewohner zu optimieren. Dies...

Interventions to optimise prescribing for older people in care homes

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

J. Bauer: wissenschaftliche Förderung: Nestlé, Nutricia Danone; Beratungstätigkeit: Nestlé, Nutricia Danone; Vortragshonorare: Nestlé, Nutricia Danone, Fresenius, Bayer, Novartis, Pfizer. Sämtliche Einnahmen aus obigen Tätigkeiten gehen an seine Institution. S. Voigt-Radloff, C. Bollig, G. Torbahn und M. Denkinger geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P (2013) Interventions to optimise prescribing for older people in carehomes. Cochrane Database of Systematic Reviews, Issue 2.  https://doi.org/10.1002/14651858.CD009095.pub2 CrossRefPubMedGoogle Scholar
  2. 2.
    Nyborg G, Brekke M, Straand J, Gjelstad S, Romoren M (2017) Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria. BMC Geriatr 17(1):220CrossRefGoogle Scholar
  3. 3.
    Endres HG, Kaufmann-Kolle P, Steeb V, Bauer E, Bottner C, Thurmann P (2016) Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS ONE 11(2):e146811CrossRefGoogle Scholar
  4. 4.
    Richter T, Mann E, Meyer G, Haastert B, Kopke S (2012) Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc 13(2):187.e7–187.e13CrossRefGoogle Scholar
  5. 5.
    Davies EA, O’Mahony MS (2015) Adverse drug reactions in special populations—the elderly. Br J Clin Pharmacol 80(4):796–807CrossRefGoogle Scholar
  6. 6.
    Hoffmann F, Boeschen D, Dorks M, Herget-Rosenthal S, Petersen J, Schmiemann G (2016) Renal insufficiency and medication in nursing home residents. A cross-sectional study (IMREN). Dtsch Ärztebl Int 113(6):92–98PubMedPubMedCentralGoogle Scholar
  7. 7.
    Bakken MS, Schjott J, Engeland A, Engesaeter LB, Ruths S (2016) Antipsychotic drugs and risk of hip fracture in people aged 60 and older in Norway. J Am Geriatr Soc 64(6):1203–1209CrossRefGoogle Scholar
  8. 8.
    Cioltan H, Alshehri S, Howe C, Lee J, Fain M, Eng H et al (2017) Variation in use of antipsychotic medications in nursing homes in the United States: a systematic review. BMC Geriatr 17(1):32CrossRefGoogle Scholar
  9. 9.
    Liperoti R, Sqanqa F, Landi F, Topinkova E, Denkinger MD, van der Roest HG et al (2017) Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J Clin Psychiatry 78:e76–e82CrossRefGoogle Scholar
  10. 10.
    Houghton J, Kirthisinga V, Desborough JA (2014) Multi-professional medication reviews in care homes for older people: results from the CARE MED randomized controlled trial. Age Ageing 43:ii19–ii20CrossRefGoogle Scholar
  11. 11.
    Desborough J, Houghton J, Wood J, Wright D, Holland R, Sach T, Ashwell S, Shaw V (2011) Multi-professional clinical medication reviews in care homes for the elderly: study protocol for a randomised controlled trial with cost effectiveness analysis. Trials 12:218CrossRefGoogle Scholar
  12. 12.
    Kovach CR, Hekel B, Rababa M (2015) Feasibility testing of a protocol to stop ineffective drug and nondrug treatments. West J Nurs Res 37(11):1404–1422CrossRefGoogle Scholar
  13. 13.
    Potter K, Flicker L, Page A, Etherton-Beer C (2016) Deprescribing in frail older people: a randomised controlled trial. PLoS ONE 11(3):e149984.  https://doi.org/10.1371/journal.pone.0149984 (eCollection 2016)CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wouters H, Scheper J, Koning H, Brouwer C, Twisk JW, van der Meer H, Boersma F, Zuidema SU, Taxis K (2017) Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial. Ann Intern Med 167(9):609–617CrossRefGoogle Scholar
  15. 15.
    Anrys P, Strauven G, Boland B et al (2016) Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial. Implement Sci 11:35CrossRefGoogle Scholar
  16. 16.
    Strauven G, Anrys P, Vandael E, Henrard S, De Lepeleire J, Spinewine A, Foulon V (2019) Cluster-controlled trial of an intervention to improve prescribing in nursing homes study. J Am Med Dir Assoc 20(11):1404–1411CrossRefGoogle Scholar
  17. 17.
    Husebø BS, Ballard C, Aarsland D, Selbaek G, Slettebo DD, Gulla C, Aasmul I, Habiger T, Elvegaard T, Testad I, Flo E (2019) The effect of a multicomponent intervention on quality of life in residents of nursing homes: a randomized controlled trial (COSMOS). J Am Med Dir Assoc 20(3):330–339CrossRefGoogle Scholar
  18. 18.
    Gulla C, Flo E, Kjome RLS, Husebo BS (2019) Implementing a novel strategy for interprofessional medication review using collegial mentoring and systematic clinical evaluation in nursing homes (COSMOS). BMC Geriatr 19(1):130CrossRefGoogle Scholar
  19. 19.
    Millar AN, Daffu-O’Reilly A, Hughes CM et al (2017) Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes. Trials 18(1):175CrossRefGoogle Scholar
  20. 20.
    Beuscart JB, Knol W, Cullinan S et al (2018) International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med 16:21CrossRefGoogle Scholar
  21. 21.
    Cameron ID, Dyer SM, Panagoda CE, Murray GR, Hill KD, Cumming RG, Kerse N (2018) Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 9:CD5465PubMedGoogle Scholar
  22. 22.
    Richter T, Meyer G, Möhler R, Köpke S (2012) Psychosocial interventions for reducing antipsychotic medication in care home residents. Cochrane Database Syst Rev 12:CD8634PubMedGoogle Scholar
  23. 23.
    Crocker T, Forster A, Young J, Brown L, Ozer S, Smith J, Green J, Hardy J, Burns E, Glidewell E, Greenwood DC (2013) Physical rehabilitation for older people in long-term care. Cochrane Database Syst Rev 2:CD4294Google Scholar
  24. 24.
    Watt JA, Goodarzi Z, Veroniki AA et al (2019) Comparative efficacy of interventions for aggressive and agitated behaviors in dementia. Ann Intern Med 171(9):633–642CrossRefGoogle Scholar
  25. 25.
    Ho JM, Tung J, Maitland J, Mangin D, Thabane L, Pavlin JM, Alfonsi J, Holbrook A, Straus S, Benjamin S (2018) GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647). Pilot Feasibility Stud 4:116CrossRefGoogle Scholar
  26. 26.
    Krause O, Wiese B, Doyle IM, Kirsch C, Thürmann P, Wilm S, Sparenberg L, Stolz R, Freytag A, Bleidorn J, Junius-Walker U (2019) Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study). BMC Geriatr 19(1):24CrossRefGoogle Scholar
  27. 27.
    Kua CH, Yeo CYY, Char CWT, Tan CWY, Tan PC, Mak VS, Lee SWH, Leong IY (2017) Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol. BMJ Open 7(5):e15293CrossRefGoogle Scholar
  28. 28.
    Mestres Gonzalvo C, de Wit HA, van Oijen BP, Hurkens KP, Janknegt R, Schols JM, Mulder WJ, Verhey FR, Winkens B, van der Kuy PM (2017) Supporting clinical rules engine in the adjustment of medication (SCREAM): protocol of a multicentre, prospective, randomised study. BMC Geriatr 17(1):35CrossRefGoogle Scholar
  29. 29.
    Pouw CAM, Smalbrugge M, van Marum RJ, Hugtenburg JG, Hertogh CMPM (2018) Improving medication prescription in the context of advanced care planning for patients receiving nursing home care (IMPETUS): study protocol of a cluster randomized controlled trial. Int J Clin Pharm 40(2):489–489Google Scholar
  30. 30.
    Sluggett JK, Chen EYH, Ilomäki J, Corlis M, Hilmer SN, Van Emden J, Ooi CE, Nguyen KH, Comans T, Hogan M, Caporale T, Edwards S, Quirke L, Patching A, Bell JS (2018) SImplification of Medications Prescribed to Long-tErm care Residents (SIMPLER): study protocol for a cluster randomised controlled trial. Trials 19(1):37CrossRefGoogle Scholar
  31. 31.
    U.S. National Library of Medicine (2016) Enhancing the detection and management of adverse drug events in nursing homes. https://clinicaltrials.gov/show/nct01531088. Zugegriffen: 3. Dezember 2019
  32. 32.
    U.S. National Library of Medicine (2014) Pharmaceutical care in VA nursing home. https://clinicaltrials.gov/show/nct01823757. Zugegriffen: 3. Dezember 2019
  33. 33.
    U.S. National Library of Medicine (2019) Deprescribing in a long term care facility. https://clinicaltrials.gov/show/nct03091153. Zugegriffen: 3. Dezember 2019
  34. 34.
    U.S. National Library of Medicine (2018) Impact of a hospital medication expertise on unplanned hospitalizations at 3 months of nursing homes patients (TEM-EHPAD). https://clinicaltrials.gov/show/NCT03640845. Zugegriffen: 3. Dezember 2019
  35. 35.
    U.S. National Library of Medicine (2019) Randomised, controlled trial of an individual deprescribing intervention for nursing homes residents (OLD-NH-IdeI). https://clinicaltrials.gov/show/NCT03655405. Zugegriffen: 3. Dezember 2019
  36. 36.
    U.S. National Library of Medicine (2018) Opportunities and limits to deprescribing in nursing homes:quality circle deprescribing module (OLD-NH-QC-deMo). https://clinicaltrials.gov/show/NCT03688542. Zugegriffen: 3. Dezember 2019
  37. 37.
    U.S. National Library of Medicine (2019) Psychotropic drug use in the elderly living in nursing homes and the influence of a structured drug review. https://clinicaltrials.gov/show/NCT03736577. Zugegriffen: 3. Dezember 2019

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Sebastian Voigt-Radloff
    • 1
    • 2
    Email author
  • Claudia Bollig
    • 2
  • Gabriel Torbahn
    • 2
  • Michael Denkinger
    • 3
  • Jürgen Bauer
    • 4
  1. 1.Zentrum für Geriatrie und Gerontologie Freiburg, Universitätsklinikum Freiburg, Medizinische FakultätAlbert-Ludwigs-Universität FreiburgFreiburgDeutschland
  2. 2.Institut für Evidenz in der Medizin (für Cochrane Deutschland Stiftung), Universitätsklinikum Freiburg, Medizinische FakultätAlbert-Ludwigs-Universität FreiburgFreiburgDeutschland
  3. 3.AGAPLESION Bethesda Ulm, Geriatrisches Zentrum Ulm/Alb-DonauGeriatrische Forschung der Universität UlmUlmDeutschland
  4. 4.Geriatrisches ZentrumUniversität HeidelbergHeidelbergDeutschland

Personalised recommendations